These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17213470

  • 1. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E.
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
    [Abstract] [Full Text] [Related]

  • 2. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E, Cooper M, Severson DL, Larsen TS.
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [Abstract] [Full Text] [Related]

  • 3. Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart.
    Panagia M, Schneider JE, Brown B, Cole MA, Clarke K.
    Can J Physiol Pharmacol; 2007 Feb; 85(3-4):289-94. PubMed ID: 17612636
    [Abstract] [Full Text] [Related]

  • 4. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
    Oakes ND, Thalén P, Aasum E, Edgley A, Larsen T, Furler SM, Ljung B, Severson D.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
    [Abstract] [Full Text] [Related]

  • 5. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC.
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [Abstract] [Full Text] [Related]

  • 6. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart.
    Wang P, Lloyd SG, Chatham JC.
    Circulation; 2005 Apr 26; 111(16):2066-72. PubMed ID: 15824201
    [Abstract] [Full Text] [Related]

  • 7. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, Severson DL.
    Am J Physiol Endocrinol Metab; 2004 Mar 26; 286(3):E449-55. PubMed ID: 14600074
    [Abstract] [Full Text] [Related]

  • 8. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
    Folmes CD, Clanachan AS, Lopaschuk GD.
    Circ Res; 2006 Jul 07; 99(1):61-8. PubMed ID: 16741157
    [Abstract] [Full Text] [Related]

  • 9. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
    Lopaschuk GD, Wambolt RB, Barr RL.
    J Pharmacol Exp Ther; 1993 Jan 07; 264(1):135-44. PubMed ID: 8380856
    [Abstract] [Full Text] [Related]

  • 10. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
    Neitzel AS, Carley AN, Severson DL.
    Am J Physiol Endocrinol Metab; 2003 Feb 07; 284(2):E357-65. PubMed ID: 12397026
    [Abstract] [Full Text] [Related]

  • 11. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
    Wu L, Belardinelli L, Fraser H.
    J Cardiovasc Pharmacol; 2008 Apr 07; 51(4):372-9. PubMed ID: 18427280
    [Abstract] [Full Text] [Related]

  • 12. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
    Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR.
    Circulation; 2004 Mar 30; 109(12):1550-7. PubMed ID: 15023869
    [Abstract] [Full Text] [Related]

  • 13. Heat stress induces rapid recovery of mechanical function of ischemic fatty acid perfused hearts by stimulating glucose oxidation during reperfusion.
    Broderick TL, Currie RW, Paulson DJ.
    Can J Physiol Pharmacol; 1997 Dec 30; 75(12):1273-9. PubMed ID: 9534936
    [Abstract] [Full Text] [Related]

  • 14. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
    Dyck JR, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M, Kawase Y, Jishage K, Lopaschuk GD.
    Circulation; 2006 Oct 17; 114(16):1721-8. PubMed ID: 17030679
    [Abstract] [Full Text] [Related]

  • 15. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
    Belke DD, Larsen TS, Gibbs EM, Severson DL.
    Am J Physiol Endocrinol Metab; 2000 Nov 17; 279(5):E1104-13. PubMed ID: 11052966
    [Abstract] [Full Text] [Related]

  • 16. Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes.
    Ramanathan T, Morita S, Huang Y, Shirota K, Nishimura T, Zheng X, Hunyor SN.
    Ann Thorac Surg; 2004 Apr 17; 77(4):1408-14. PubMed ID: 15063275
    [Abstract] [Full Text] [Related]

  • 17. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
    Aasum E, Hafstad AD, Severson DL, Larsen TS.
    Diabetes; 2003 Feb 17; 52(2):434-41. PubMed ID: 12540618
    [Abstract] [Full Text] [Related]

  • 18. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Carroll R, Carley AN, Dyck JR, Severson DL.
    Am J Physiol Endocrinol Metab; 2005 May 17; 288(5):E900-6. PubMed ID: 15632103
    [Abstract] [Full Text] [Related]

  • 19. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
    Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM.
    Can J Physiol Pharmacol; 2007 May 17; 85(5):527-35. PubMed ID: 17632588
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
    Lopaschuk GD, Barr R, Thomas PD, Dyck JR.
    Circ Res; 2003 Aug 08; 93(3):e33-7. PubMed ID: 12869392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.